507 results
Page 4 of 26
8-K
EX-99.1
lwmeafyzp m1
21 Dec 20
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
8:39am
8-K/A
EX-99.1
amczo
10 Dec 20
Financial Statements and Exhibits
4:13pm
8-K
EX-99.1
qdfq23g714fqukj jbv
30 Oct 20
Ligand Reports Third Quarter 2020 Financial Results
8:03am
8-K
EX-99.1
7zudge ax2hwdj
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-2.1
fl5a6oei
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
EX-99.1
4855m4p4
1 Oct 20
Contingent Value Rights Agreement
8:42am
8-K
EX-10.2
umk0f2cpygvxp oa
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
38anamwyje3 iyj98sbh
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.3
vakttau bq1
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-T
EX-99
m25mtl xzj7d5s9ha
31 Aug 20
Third party tender offer statement
8:46am
SC TO-T
EX-99
v1to d75a
31 Aug 20
Third party tender offer statement
8:46am
SC TO-T
EX-99
l1hfcx6h
31 Aug 20
Third party tender offer statement
8:46am
SC TO-C
EX-99.1
iwgd ldkqe
10 Aug 20
Information about tender offer
9:52pm
SC TO-C
EX-2.1
39n02x7
10 Aug 20
Information about tender offer
9:50pm
SC TO-C
EX-99.1
7wyg0m5x
10 Aug 20
Information about tender offer
9:50pm
SC TO-C
EX-99.2
hmgth8ym
10 Aug 20
Information about tender offer
9:50pm